37 results on '"Valipour, Arschang"'
Search Results
2. Bronchoscopic Thermal Vapor Ablation (BTVA) in patients with severe upper lobe predominant emphysema: 36 months follow-up results from a prospective registry
3. The impact of diagnostic delay on survival in alpha-1-antitrypsin deficiency - results from the Austrian Alpha-1 Lung Registry
4. Targeted lung denervation in patients with moderate to severe COPD: AIRFLOW-2 crossover patient outcomes
5. Arterial blood gases changes after endoscopic lung volume reduction
6. Characteristics of patients with homogeneous and heterogeneous emphysema
7. A modified staged treatment algorithm using the AeriSeal System
8. Late Breaking Abstract - Real-world evidence of dual bronchodilator therapy using Clinical COPD Questionnaire in 4700 COPD patients
9. Real world safety of bronchoscopic thermal vapor ablation in a multinational registry
10. Efficacy and safety of the 9mm intrabronchial valves (IBV) in patients with advanced emphysema
11. Late Breaking Abstract - Bronchial Rheoplasty For Treatment of Chronic Bronchitis: 6 Month Results from a Prospective Multi-Center Study
12. A double-blind, randomized, sham-controlled study of Targeted Lung Denervation in patients with moderate to severe COPD : AIRFLOW-2 One Year Outcomes
13. Improvement of self-reported physical functioning with tiotropium/olodaterol in Central and Eastern European COPD patients
14. Late Breaking Abstract - First-in-Human Results of Bronchial Rheoplasty: An Endobronchial Treatment For Chronic Bronchitis (CB)
15. A double-blind, randomized, sham-controlled study of Targeted Lung Denervation in patients with moderate to severe COPD
16. Removal of diseased emphysematous tissue with bronchoscopic thermal vapor ablation (BTVA)
17. Late Breaking Abstract - Bronchoscopic Thermal Vapor Ablation (BTVA) Outcomes at 12 months in Emphysema Patients with Severe Hyperinflation, a STEP-UP RCT Subgroup Analysis
18. Targeted Lung Denervation improves COPD symptoms and health related quality of life at 6-months
19. STEP-UP randomized controlled trial of vapor ablation in patients with severe emphysema: 12 month results
20. Targeted segmental volume reduction with vapor ablation in emphysema results in reduced RV and clinically meaningful improvement (CMI) in FEV1
21. Volume changes after segmental vapor ablation and associated improvements in FEV1
22. CAT in COPD phenotypes (POPE study)
23. LATE-BREAKING ABSTRACT: A multicenter, prospective, randomized, controlled trial of endobronchial valve therapy vs standard of care in homogeneous emphysema (IMPACT)
24. Pharmacotherapy of COPD in Central and Eastern Europe - The POPE study
25. Intrabronchial valve treatment in patients with severe heterogeneous emphysema and intact interlobar fissures
26. Long-term safety of bilateral targeted lung denervation in patients with COPD in a single procedure
27. LATE-BREAKING ABSTRACT: Phenotypes of COPD in central and Eastern Europe - The POPE study
28. LATE-BREAKING ABSTRACT: Treating the most diseased segments in patients with severe emphysema: 6 month results from the STEP-UP randomized controlled trial (RCT)
29. The Localized Inflammatory Response To Bronchoscopic Thermal Vapor Ablation (InterVapor) In Patients With Emphysema
30. The Influence Of GOLD Stage On The Magnitude Of Benefit Following Endoscopic Thermal Vapor Ablation (InterVaporTM) In Patients With Heterogeneous Emphysema
31. Consistent Lobar Volume Reduction Throughout 12 Months Following Bronchoscopic Thermal Vapor Ablation In Patients With Upper Lobe Predominant Emphysema
32. Endobronchial Valve Therapy Improves BODE Index In Patients With Advanced Emphysema
33. VAPOR Trial: 12 Month Efficacy And Safety Following Endoscopic Thermal Vapor Ablation (InterVapor") For Patients With Heterogeneous Emphysema
34. Long Term Follow-Up Of Patients Treated With Endobronchial One-Way Valves For Persistent Bronchopleural Fistulas
35. The Efficacy Of Bronchoscopic Thermal Vapor Ablation (BTVA) In Patients With Upper Lobe Emphysema
36. Endobronchial Valves For Emphysema Palliation Trial - The Euro Vent Trial
37. Insulin Resistance May Contribute To Systemic Vascular Dysfunction In Patients With COPD
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.